Your browser doesn't support javascript.
loading
Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing.
Akiba, Hiroki; Ise, Tomoko; Nagata, Satoshi; Kamada, Haruhiko; Ohno, Hiroaki; Tsumoto, Kouhei.
Afiliação
  • Akiba H; Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan. hakiba@pharm.kyoto-u.ac.jp.
  • Ise T; Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan. hakiba@pharm.kyoto-u.ac.jp.
  • Nagata S; Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan.
  • Kamada H; Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan.
  • Ohno H; Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan.
  • Tsumoto K; Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.
Sci Rep ; 11(1): 19411, 2021 09 30.
Article em En | MEDLINE | ID: mdl-34593913
A major class of bispecific antibodies (BsAbs) utilizes heterodimeric Fc to produce the native immunoglobulin G (IgG) structure. Because appropriate pairing of heavy and light chains is required, the design of BsAbs produced through recombination or reassembly of two separately-expressed antigen-binding fragments is advantageous. One such method uses intein-mediated protein trans-splicing (IMPTS) to produce an IgG1-based structure. An extra Cys residue is incorporated as a consensus sequence for IMPTS in successful examples, but this may lead to potential destabilization or disturbance of the assay system. In this study, we designed a BsAb linked by IMPTS, without the extra Cys residue. A BsAb binding to both TNFR2 and CD30 was successfully produced. Cleaved side product formation was inevitable, but it was minimized under the optimized conditions. The fine-tuned design is suitable for the production of IgG-like BsAb with high symmetry between the two antigen-binding fragments that is advantageous for screening BsAbs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Imunoglobulina G / Fragmentos Fab das Imunoglobulinas / Engenharia de Proteínas / Anticorpos Biespecíficos Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Imunoglobulina G / Fragmentos Fab das Imunoglobulinas / Engenharia de Proteínas / Anticorpos Biespecíficos Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão